Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Issaka Zongo

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
The Lancet. Infectious Diseases|November 26, 2015
Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trialIssaka Sagara, Abdoul Habib Beavogui, Issaka Zongo, et al.
The Lancet. Infectious Diseases|November 3, 2022
Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine-pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance studyKhalid B Beshir, Julian Muwanguzi, Johanna Nader, et al.
NPJ Vaccines|February 6, 2025
The anti-circumsporozoite antibody response to repeated, seasonal booster doses of the malaria vaccine RTS,S/AS01<sub>E</sub>M Sanni Ali, Lisa Stockdale, Issaka Sagara, et al.
The Lancet. Infectious Diseases|August 25, 2023
Seasonal vaccination with RTS,S/AS01<sub>E</sub> vaccine with or without seasonal malaria chemoprevention in children up to the age of 5 years in Burkina Faso and Mali: a double-blind, randomised, controlled, phase 3 trialAlassane Dicko, Jean-Bosco Ouedraogo, Issaka Zongo, et al.
Nature|June 23, 2012
Analysis of Plasmodium falciparum diversity in natural infections by deep sequencingMagnus Manske, Olivo Miotto, Susana Campino, et al.
The American Journal of Tropical Medicine and Hygiene|July 23, 2014
Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquineMeera Venkatesan, Nahla B Gadalla, Kasia Stepniewska, et al.
Nature Genetics|April 30, 2013
Multiple populations of artemisinin-resistant Plasmodium falciparum in CambodiaOlivo Miotto, Jacob Almagro-Garcia, Magnus Manske, et al.
BMC Medicine|April 19, 2015
The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data, Martin A Adjuik, Richard Allan, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
The Lancet. Infectious Diseases|November 26, 2015
Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trialIssaka Sagara, Abdoul Habib Beavogui, Issaka Zongo, et al.
The Lancet. Infectious Diseases|November 3, 2022
Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine-pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance studyKhalid B Beshir, Julian Muwanguzi, Johanna Nader, et al.
NPJ Vaccines|February 6, 2025
The anti-circumsporozoite antibody response to repeated, seasonal booster doses of the malaria vaccine RTS,S/AS01<sub>E</sub>M Sanni Ali, Lisa Stockdale, Issaka Sagara, et al.
The Lancet. Infectious Diseases|August 25, 2023
Seasonal vaccination with RTS,S/AS01<sub>E</sub> vaccine with or without seasonal malaria chemoprevention in children up to the age of 5 years in Burkina Faso and Mali: a double-blind, randomised, controlled, phase 3 trialAlassane Dicko, Jean-Bosco Ouedraogo, Issaka Zongo, et al.
Nature|June 23, 2012
Analysis of Plasmodium falciparum diversity in natural infections by deep sequencingMagnus Manske, Olivo Miotto, Susana Campino, et al.
The American Journal of Tropical Medicine and Hygiene|July 23, 2014
Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquineMeera Venkatesan, Nahla B Gadalla, Kasia Stepniewska, et al.
Nature Genetics|April 30, 2013
Multiple populations of artemisinin-resistant Plasmodium falciparum in CambodiaOlivo Miotto, Jacob Almagro-Garcia, Magnus Manske, et al.
BMC Medicine|April 19, 2015
The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data, Martin A Adjuik, Richard Allan, et al.
Pageof 7